InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
61,376.77
(
0.95%
)
Post# of 2098
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

LAY01

Send PM Follow Ignore
Followers 1
Posts 58
Boards Moderated 0
Alias Born 11/28/2015

LAY01

Re: None

Monday, 12/14/2015 4:45:59 PM

Monday, December 14, 2015 4:45:59 PM

Post# of 2098
The FDA clears Zogenix's (NASDAQ:ZGNX) Investigational New Drug (IND) application for lead product candidate ZX008.

The approval allows the company to initiate its Phase 3 program for the adjunctive treatment of seizures in children with Dravet syndrome, a rare and catastrophic form of intractable epilepsy that begins in infancy.

Full story: Zogenix cleared to start late-stage studies of lead product candidate in Dravet http://www.seekingalpha.com/news/2982746
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news
Only $200 per official company press release!